Prescott Group Capital Management’s Safeguard Scientifics, Inc. SFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-23,745
Closed -$211K 215
2021
Q3
$211K Hold
23,745
0.06% 147
2021
Q2
$184K Hold
23,745
0.05% 131
2021
Q1
$162K Buy
+23,745
New +$172K 0.05% 134
2020
Q4
Sell
-204,644
Closed -$1.12M 122
2020
Q3
$1.12M Hold
204,644
0.5% 48
2020
Q2
$1.43M Sell
204,644
-2,012
-1% -$12.7K 0.71% 36
2020
Q1
$1.15M Sell
206,656
-74,607
-27% -$667K 0.57% 50
2019
Q4
$3.09M Sell
281,263
-377,221
-57% -$4.31M 1.07% 23
2019
Q3
$7.47M Sell
658,484
-64,241
-9% -$766K 2.3% 10
2019
Q2
$8.72M Sell
722,725
-56,415
-7% -$661K 2.12% 11
2019
Q1
$8.45M Sell
779,140
-100,500
-11% -$1.02M 1.73% 16
2018
Q4
$7.58M Buy
879,640
+425,988
+94% +$3.72M 1.48% 16
2018
Q3
$4.24M Buy
453,652
+343,805
+313% +$3.74M 0.83% 27
2018
Q2
$1.41M Buy
+109,847
New +$1.42M 0.26% 103

Other funds holding SFE

Prescott Group Capital Management's SFE Position: Q4 2021 in Review

Prescott Group Capital Management sold out of Safeguard Scientifics, Inc. (SFE) in Q4 2021, closing a stake of 23,745 shares — an estimated $211K sold.

Prescott Group Capital Management first reported a position in SFE in Q2 2018 and held it in 13 quarters. The position peaked at $8.72M in Q2 2019. 63 funds tracked by Wall St. Rank hold SFE as of Q4 2021.

  • Prescott Group Capital Management reported no remaining Safeguard Scientifics, Inc. position as of Q4 2021 after selling out during the quarter.
  • Prescott Group Capital Management sold 23,745 Safeguard Scientifics, Inc. shares in Q4 2021, an estimated $211K.
  • Prescott Group Capital Management first reported a position in Safeguard Scientifics, Inc. in Q2 2018 and held it in 13 quarters.
  • Prescott Group Capital Management's Safeguard Scientifics, Inc. position peaked at $8.72M in Q2 2019.
  • 63 funds tracked by Wall St. Rank held Safeguard Scientifics, Inc. as of Q4 2021.

Based on Prescott Group Capital Management's 13F filing for Q4 2021, filed 10 Feb 2022.